Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Perry Jodi Create: Alert

All | News | Filings
Date FiledTypeDescription
02/08/2023 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Sold 6,343 shares @ $112.3, valued at $712.3k
01/05/2023 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 176 shares @ $106.11, valued at $18.7k
12/16/2022 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Granted 5,440 restricted stock units @ $0
Granted 4,533 restricted stock units @ $0
Granted 907 restricted stock units @ $0
12/14/2022 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 1,062 shares @ $114.58, valued at $121.7k
Paid exercise price by delivering 178 shares @ $111.52, valued at $19.9k
Exercised 2,700 restricted stock units @ $0
Exercised 453 restricted stock units @ $0
12/01/2022 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 365 shares @ $115.37, valued at $42.1k
Granted 594 shares @ $0
Exercised 1,500 restricted stock units @ $0
11/25/2022 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 73 shares @ $123.52, valued at $9k
Paid exercise price by delivering 1,095 shares @ $123.52, valued at $135.3k
Exercised 300 restricted stock units @ $0
Exercised 4,500 restricted stock units @ $0
01/05/2022 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 126 shares @ $102.86, valued at $13k
12/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/01/2021 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 1,095 shares @ $100.57, valued at $110.1k
Paid exercise price by delivering 73 shares @ $98.29, valued at $7.2k
Exercised 4,500 restricted stock units @ $0
Exercised 300 restricted stock units @ $0
11/23/2021 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 73 shares @ $98.64, valued at $7.2k
Exercised 300 restricted stock units @ $0
05/21/2021 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Sold 1,850 shares @ $132.9401, valued at $245.9k
03/04/2021 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Sold 1,264 shares @ $119.5017, valued at $151.1k
12/17/2020 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 63 shares @ $93.49, valued at $5.9k
Exercised 262 restricted stock units @ $0
Granted 301 restricted stock units @ $0
12/04/2020 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Granted 5,000 restricted stock units @ $0
12/02/2020 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 48 shares @ $90.95, valued at $4.4k
Exercised 200 restricted stock units @ $0
11/24/2020 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 146 shares @ $88.51, valued at $12.9k
Exercised 600 restricted stock units @ $0
11/23/2020 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 48 shares @ $89.2, valued at $4.3k
Exercised 200 restricted stock units @ $0
11/20/2020 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Sold 659 shares @ $90.08, valued at $59.4k
03/13/2020 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Exercised 1,400 options to buy @ $55.49, valued at $77.7k
Exercised 400 options to buy @ $48.2, valued at $19.3k
12/16/2019 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 50 shares @ $90.88, valued at $4.5k
Granted 3,000 restricted stock units @ $0
Granted 302 restricted stock units @ $0
Exercised 206 restricted stock units @ $0
12/03/2019 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 146 shares @ $89.82, valued at $13.1k
Exercised 600 restricted stock units @ $0
11/25/2019 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Granted 5,000 restricted stock units @ $0
11/21/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/18/2018 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Granted 225 restricted stock units @ $0
12/06/2018 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 50 shares @ $76.25, valued at $3.8k
Exercised 206 restricted stock units @ $0
11/30/2018 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Granted 5,000 restricted stock units @ $0
11/21/2018 4 Perry Jodi (President, ICD for RJFS) has filed a Form 4 on RAYMOND JAMES FINANCIAL INC
Txns: Paid exercise price by delivering 142 shares @ $77.91, valued at $11.1k
Exercised 600 restricted stock units @ $0
10/18/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/31/2018 3 Perry Jodi (President, ICD for RJFS) has filed a Form 3 on RAYMOND JAMES FINANCIAL INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy